California Public Employees Retirement System’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-36,700
Closed -$890K 1710
2021
Q1
$890K Sell
36,700
-3,407
-8% -$91.9K ﹤0.01% 2576
2020
Q4
$1.28M Buy
40,107
+2,607
+7% +$85.6K ﹤0.01% 2302
2020
Q3
$1.13M Buy
37,500
+10,276
+38% +$313K ﹤0.01% 2192
2020
Q2
$1.15M Buy
+27,224
New +$1M ﹤0.01% 2133

Other funds holding BDTX

California Public Employees Retirement System's BDTX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Black Diamond Therapeutics (BDTX) in Q2 2021, closing a stake of 36,700 shares — an estimated $890K sold.

California Public Employees Retirement System first reported a position in BDTX in Q2 2020 and held it in 4 quarters. The position peaked at $1.28M in Q4 2020. 102 funds tracked by Wall St. Rank hold BDTX as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Black Diamond Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 36,700 Black Diamond Therapeutics shares in Q2 2021, an estimated $890K.
  • California Public Employees Retirement System first reported a position in Black Diamond Therapeutics in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Black Diamond Therapeutics position peaked at $1.28M in Q4 2020.
  • 102 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.